Chapter 33 "Silent" cerebral infarcts and microbleeds

Handbook of Clinical Neurology

Volumn 93, Issue , 2008, Pages 667-681

  Norrving, Bo ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66049109641     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(08)93033-5     Document Type: Review

References (127)

1. Adachi T., Kobayashi S., and Yamaguchi S. Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke. Intern Med 41 (2002) 103-108
2. Bernick C., Kuller L., Dulberg C., et al. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology 57 (2001) 1222-1229
3. Birns J., Markus H., and Kalra L. Blood pressure reduction for vascular risk: is there a price to be paid?. Stroke 36 (2005) 1308-1313
4. Bokura H., Kobayashi S., and Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virshow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol 245 (1998) 116-122
5. Boon A., Lodder J., Heuts-van Raak I., et al. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Stroke 25 (1994) 2384-2390
6. Brainin M., McShane L.M., Steiner M., et al. Silent brain infarcts and transient ischemic attacks: a three-year study of first ever ischemic stroke patients: the Klosterneuburg Stroke Data Bank. Stroke 26 (1995) 1348-1352
7. Brott T., Tomsick T., Feinberg W., et al. Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study. Stroke 25 (1994) 1122-1129
8. Bryan R.N., Wells S.W., Miller T.J., et al. Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly-data from The Cardiovascular Health Study. Radiology 202 (1997) 47-54
9. Bryan R.N., Caj J., Burke G., et al. Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR 20 (1999) 1273-1280
10. Chodosh E.H., Foulkes M.A., Kase C.S., et al. Silent stroke in the NINCDS stroke data bank. Neurology 38 (1988) 1674-1679
11. Cooper L.S., Wong T.Y., Klein R., et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction. The Atherosclerosis Risk in Communities Study. Stroke 37 (2006) 82-86
12. Cordonnier C., Al-Shahi Salman R., and Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130 (2007) 1988-2003
13. Corea F., Henon H., Pasquier F., et al. Silent infarcts in stroke patients: patient characteristics and effects on 2-year outcome. J Neurol 248 (2001) 271-278
14. Coutts S.B., Hill M.D., Simon J.E., et al., for the VISION Study Group. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 65 (2005) 513-517
15. Davis P.H., Clarke W.R., Bendixen B.H., et al. Silent cerebral infarction in patients enrolled in the TOAST Study. Neurology 46 (1996) 942-948
16. DeCarli C., Massaro J., Harvey D., et al. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging 26 (2005) 491-510
17. De Groot J.C., de Leeuw F.E., Oudkerk M., et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 47 (2000) 145-151
18. De Groot J.C., de Leeuw F.E., Oudkerk M., et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 52 (2002) 335-341
19. De Jong G., Kessels F., and Lodder J. Two types of lacunar infarcts. Further arguments from a study on prognosis. Stroke 33 (2002) 2072-2076
20. De Leeuw F., de Groot J.C., Achten E., et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70 (2001) 9-14
21. De Reuck J., Sieben G., De Coster W., et al. Stroke pattern and topography of cerebral infarcts: a clinicopathological study. Eur Neurol 20 (1981) 411-415
22. Diener H.C., Bogousslavsky J., Brass L.M., et al., MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
23. Dufouil C., Chalmers J., Coskun O., et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (perindopril protection against recurrent stroke study) magnetic resonance substudy. Circulation 112 (2005) 1644-1650
24. EAFT Study Group. Silent brain infarction in nonrheumatic atrial fibrillation: EAFT Study Group European Atrial Fibrillation Trial. Neurology 46 (1996) 159-165
25. Eguchi K., Kairo K., and Shimada K. Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke 34 (2003) 2471-2474
26. Ezekowitz M.D., James K.E., Nazarian S.M., et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 92 (1995) 2178-2182
27. Fan Y.H., Zhang L., Lam W.W., et al. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhage among patients with acute ischemic stroke. Stroke 34 (2003) 2459-2462
28. Fazekas F., Kleinert R., Robb G., et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 20 (1999) 637-642
29. Feinberg W.M., Seeger J.F., Carmody R.F., et al. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med 150 (1990) 2340-2344
30. Fisher C.M. Lacunes: small deep cerebral infarcts. Neurology 15 (1965) 774-784
31. Fisher C.M. The arterial lesions underlying lacunes. Acta Neuropathol (Berlin) 12 (1969) 1-15
32. Fisher C.M. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 30 (1971) 536-550
33. Fisher C.M. Lacunar infarcts: a review. Cerebrovasc Dis 1 (1991) 311-320
34. Foerch C., Misselwitz B., Sitzer M., et al., Arbetitsgruppe Schlaganfall Hessen. Difference in recognition of right and left hemispheric stroke. Lancet 366 (2005) 392-393
35. Fujikawa T., Yamawaki S., and Youhounda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 24 (1993) 1631-1634
36. Fujikawa T., Yamawaki S., and Youhounda Y. Silent cerebral infarction in patients with late onset mania. Stroke 26 (1995) 946-949
37. Fujikawa T., Yokota N., Muraoka M., et al. Response of patients with major depression and silent cerebral infarction to antidepressant drug therapy, with emphasis on central nervous system adverse reactions. Stroke 27 (1996) 2040-2042
38. Giele J.L.P., Witkamp T.D., Mali W.P.T.M., et al., for the SMART Study Group. Silent brain infarcts in patients with manifest vascular disease. Stroke 35 (2004) 742-746
39. Goldstein I.B., Bartzokis G., Hance D.B., et al. Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke 29 (1998) 765-772
40. Greenberg S.M., Finkelstein S.P., and Schaefer P.W. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 46 (1996) 1751-1754
41. Greenberg S.M., Eng J.A., Ning M., et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 35 (2004) 1415-1420
42. Hasegawa Y., Yamaguchi T., Omae T., et al., PROGRESS CT Substudy Investigators. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarcts: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertens Res 27 (2004) 147-156
43. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54 (1976) 541-553
44. Herderschee D., Hijdra A., Algra A., et al., Trial Study Group. Silent stroke in patients with transient ischemic attack or minor ischemic stroke. Stroke 23 (1992) 1220-1224
45. Hoshi T., Kitagawa K., Yamagami H., et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36 (2005) 768-772
46. Hougaku M., Matsumoto M., Handa N., et al. Asymptomatic carotid lesions and silent cerebral infarction. Stroke 25 (1994) 566-570
47. Howard G., Wagenknecht L.E., Cai J., et al. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 29 (1998) 913-917
48. Jörgensen H.S., Nakayama H., Raaschou H.O., et al. Silent infarction in acute stroke patients. Prevalence, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke 25 (1994) 97-104
49. Jungreis C.A., Kanal E., Hirsch W.L., et al. Normal perivascular spaces mimicking lacunar infarction: MR imaging. Radiology 169 (1988) 101-104
50. Kairo K., Matsuo T., Kobayashi H., et al. Elation between nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensives: advanced silent cerebrovascular damage in extreme dippers. Hypertension 27 (1996) 130-135
51. Kairo K., Motai K., Mitsuhashi T., et al. Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal blood pressure variation. Relation to silent cerebrovascular disease. Hypertension 30 (1997) 1504-1510
52. Kang D., Charlela J.A., Ezzeddine M.A., et al. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch Neurol 60 (2003) 1730-1734
53. Kang D.W., Latour L.L., Chalela J.A., et al. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol 54 (2003) 66-74
54. Kase C.S., Wolf P.A., Chodosh E.H., et al. Prevalence of silent stroke in patients with initial stroke: the Framingham study. Stroke 20 (1989) 850-852
55. Kazui S., Levi C.R., Jones E.F., et al. Lacunar stroke: transesophageal echocardiographic factors influencing long-term prognosis. Cerebrovasc Dis 12 (2001) 325-330
56. Kempster P.A., Gerraty R.P., and Gates P.C. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. Stroke 19 (1988) 955-957
57. Knudsen K.A., Rosand J., Karluk D., et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56 (2001) 537-539
58. Kobayashi S., Okada K., and Yamashita K. Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke 22 (1991) 1379-1383
59. Kobayashi S., Okada K., Koide H., et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28 (1997) 1932-1939
60. Koennecke H. Cerebral microbleeds on MRI. Prevalence, associations, and potential clinical implications. Neurology 66 (2006) 165-171
61. Kohara K., Fujisawa M., Ando F., et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: the NILS-LSA Study. Stroke 34 (2003) 1130-1135
62. Kuller L.H., Longstreth Jr. W.T., Arnold A.M., et al. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 35 (2004) 1821-1825
63. Kuller L.H., Lopez O.L., Jagust W.J., et al. Determinants of vascular dementia in the Cardiovascular Health Study. Neurology 64 (2005) 1548-1552
64. Kwon H.M., Kim B.J., Lee S.H., et al. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37 (2006) 466-470
65. Leary M.C., and Saver J.L. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 16 (2003) 280-285
66. Lee S.C., Park S.J., Ki H.K., et al. Prevalence and risk factors of silent cerebral infarction in apparently normal adults. Hypertension 36 (2000) 73-77
67. Lee S.H., Bae H.J., Yoon B., et al. Low concentration of serum cholesterol is associated with multifocal signal loss lesions on gradient-echomagnetic resonance imaging. Analysis of risk factors for multifocal signal loss lesions. Stroke 33 (2002) 2845-2849
68. Leys D., Henon H., Mackowiak-Cordoliani M., et al. Post-stroke dementia. Lancet Neurol 4 (2005) 752-759
69. Liao D., Cooper L., Cai J., et al. Presence and severity of white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis risk in communities study. Stroke 27 (1996) 2262-2270
70. Liebetrau M., Steen B., Hamann G.F., et al. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects. Stroke 35 (2004) 1816-1820
71. Lindgren A., Roijer A., Rudling O., et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. Stroke 25 (1994) 929-934
72. Longstreth Jr. W.T., Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 (1996) 1274-1282
73. Longstreth Jr. W.T., Bernick C., Manolio T.A., et al. Lacunar infarcts defined by magnetic resonance imaging of 3600 elderly people: the Cardiovascular Health Study. Arch Neurol 55 (1998) 1217-1225
74. Longstreth Jr. W.T., Dulberg C., Manolio T.A., et al. Incidence, manifestations and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly. The Cardiovascular Health Study. Stroke 33 (2002) 2376-2382
75. Longstreth Jr. W.T., Arnold A.M., Beauchamp N.J., et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly. The Cardiovascular Health Study. Stroke 36 (2005) 56-61
76. Maeshima S., Moriwaki H., Ozaki F., et al. Silent cerebral infarction and cognitive function in middle-aged neurologically healthy subjects. Acta Neurol Scand 105 (2002) 179-184
77. Matsui T., Arai H., Yuzuriha T., et al. Elevated plasma homocysteine levels and risk of silent brain infarcts in elderly people. Stroke 32 (2001) 1116-1119
78. Minn Y., Cho S., Lee J., et al. Significance of silent infarcts in acute ischemic stroke patients aged 80 years and older. Cerebrovasc Dis 20 (2005) 92-96
79. Modrego Pardo P.J., Labrador Fuster T., and Torres Nuez J. Silent brain infarction in patients with coronary heart disease. J Neurol 245 (1998) 93-97
80. Mosley T.H., Knopman D.S., Catellier D.J., et al. Cerebral MRI findings and cognitive functioning. The Atherosclerosis Risk in Communities Study. Neurology 64 (2005) 2056-2062
81. Mounier-Vehier F., Leys D., Rondepierre P., et al. Silent infarcts in patients with ischemic stroke are related to age and signs of the left atrium. Stroke 24 (1993) 1347-1351
82. Norris J.W., and Zhu C.Z. Silent stroke and carotid stenosis. Stroke 23 (1992) 483-485
83. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2 (2003) 238-245
84. Norrving B., and Bogousslavsky J. Side asymmetries in hemispheric stroke. J Neurol 1991 (1991) 121
85. Notsu Y., Nabika T., Park H.Y., et al. Evaluation of genetic risk factors of silent brain infarction. Stroke 30 (1999) 1881-1886
86. Offerbacher H., Fazekas F., Schmidt R., et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR 17 (1996) 573-578
87. Osborn A.G., Weller R.O., Salzman K.L., et al. Imaging of brain perivascular spaces. Riv Neuroradiol 16 (2003) 55-58
88. Pantoni L., and Garcia J.H. Pathogenesis of leucoaraiosis: a review. Stroke 28 (1997) 652-659
89. Petersen P., Madsen E.B., Brun B., et al. Silent cerebral infarction in chronic atrial fibrillation. Stroke 18 (1987) 1098-1100
90. Petersen P., Pedersen F., and Johnson A. Cerebral computed tomography in paroxysmal atrial fibrillation. Acta Neurol Scand 79 (1989) 482-486
91. Phillips S.J., Whisnant J.P., O'Fallon W.M., et al. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 65 (1990) 344-359
92. Price T.R., Manolio T.A., Kronmal R.A., et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study CHS Collaborative Research Group. Stroke 28 (1997) 1158-1164
93. Prins N.D., van Dijk E.J., den Heijer T., et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128 (2005) 2034-2041
94. Pullicino P.M., Miller L.L., Alexandrov A.V., et al. Infraputaminal "lacunes". Clinical and pathological correlations. Stroke 26 (1995) 1598-1602
95. Rasquin S.M.C., Verhey F.R.J., van Oostenbrugge R.J., et al. Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry 75 (2004) 1562-1567
96. Ricci S., Celani M.G., La Rosa F., et al. Silent brain infarctions in patients with first-ever stroke. Stroke 24 (1993) 647-651
97. Robb G., Schmidt R., Kapeller P., et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 52 (1999) 991-994
98. Rosand J., Mizukansky A., Kumar A., et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 58 (2005) 459-462
99. Samuelsson M., Söderfelt B., and Olsson G.B. Functional outcome in patients with lacunar infarction. Stroke 27 (1996) 842-846
100. Schatz J., White D.A., Moinuddin A., et al. Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol 17 (2002) 891-895
101. Schmidt R., Ropele S., Enzinger C., et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention Study. Ann Neurol 58 (2005) 610-616
102. Shimada K., Kawamoto A., Matsubayashi K., et al. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 16 (1990) 692-699
103. Shinkawa A., Ueda K., Kiyohara Y., et al. Silent cerebral infarction in a community-based autopsy series in Japan: the Hisayama study. Stroke 26 (1995) 380-385
104. Shinoda-Tagawa T., Yamasaki Y., Yoshida S., et al. A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with type II diabetes. Diabetologica 45 (2002) 188-194
105. Staaf G., Lindgren A., and Norrving B. Pure motor stroke from presumed lacunar infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke 32 (2001) 2592-2596
106. Steffens D.C., Helms M.J., Krishnan K.R., et al. Cardiovascular disease and depression symptoms in the Cardiovascular Health Study. Stroke 30 (1999) 2159-2166
107. Steffens D.C., Krishnan R.R., Crump C., et al. Cerebrovascular disease and evolution of depressive symptoms in the Cardiovascular Health Study. Stroke 30 (2002) 1636-1644
108. Streifler J.Y., Fox A.J., Wong C.J., et al. Importance of "silent" brain infarctions in TIA patients with high-grade carotid stenosis: results from NASCET. Neurology 42 suppl 3 (1992) 204 Abstract
109. Takao M., Koto A., Tanahashi N., et al. Pathologic finding of silent, small hyperintense foci in the basal ganglia and thalamus on MRI. Neurology 52 (1999) 666-668
110. Tanaka A., Ueno Y., Nakayama Y., et al. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 30 (1999) 1637-1642
111. Ten Dam V.H., van den Heuvel D.M., van Buchem M.A., et al., PROSPER Study Group. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 64 (2005) 1807-1809
112. The Dutch TIA Trial Study Group. Predictors of major vascular events in patients with transient ischemic attack or nondisabling stroke. Stroke 24 (1993) 527-531
113. Van der Flier W.M., van Straaten E., Barkhof F., et al. Small vessel disease and general cognitive function in non-disabled elderly: the LADIS study. Stroke 36 (2005) 2116-2120
114. Van Dijk E.J., Prins N.D., Vermeer S.E., et al. C-reactive protein and cerebral small-vessel disease. The Rotterdam Scan Study. Circulation 112 (2005) 900-905
115. Van Swieten J.C., Kappelle L.J., Algra A., et al. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke: Dutch TIA Trial Study Group. Ann Neurol 32 (1992) 177-183
116. Van Zagten M., Boiten J., Kessels F., et al. Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch Neurol 53 (1996) 650-655
117. Vermeer S.E., Koudstaal P.J., Oudkerk M., et al. Prevalence and risk-factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 33 (2002) 21-25
118. Vermeer S.E., van Dijk E.J., Koudstaal P.J., et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 51 (2002) 285-289
119. Vermeer S.E., den Heijer T., Koudstaal P.J., et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34 (2003) 392-396
120. Vermeer S.E., Hollander M., van Dijk E.J., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population. The Rotterdam Scan Study. Stroke 34 (2003) 1126-1129
121. Vermeer S.E., Prins N.D., den Heijer T., et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348 (2003) 1215-1222
122. Viswanathan A., and Chabriat H. Cerebral microhemorrhage. Stroke 37 (2006) 550-555
123. Waldstein S.R., Siegel E.L., Lefkowitz D., et al. Stress-induced blood pressure reactivity and silent cerebrovascular disease. Stroke 35 (2004) 1294-1298
124. Wang W., Enos L., Gallagher D., et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study on Sickle Cell Disease. J Pediatr 139 (2001) 391-397
125. Werring D.J., Frazer D.W., Coward L.J., et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 127 (2004) 2265-2275
126. Werring D.J., Coward L.J., Losseff N.A., et al. Cerebral microbleeds are common in ischemic stroke but rare in TIA. Neurology 65 (2005) 1914-1918
127. Yamamoto Y., Akiguchi I., Oiwa K., et al. Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct. Stroke 2002 (2002) 297-305